S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

NCT00433446 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
62
Enrollment
NETWORK
Sponsor class

Conditions

Interventions

Sponsor

SWOG Cancer Research Network

Collaborators